Moelis & Company (MC) Earnings Call Transcript & Summary

February 4, 2026

New York Stock Exchange US Financials Capital Markets earnings 45 min

Earnings Call Speaker Segments

Matthew Tsukroff

executive
#1

Thanks for being with us this afternoon for Moelis & Company's call covering results for the fourth quarter and the full 2025 fiscal year. Joining us on the line are Navid Mahmoodzadegan, our Chief Executive Officer and Co-Founder, along with Chris Callagaro, who serves as Chief Financial Officer. Ahead of getting started, please be aware that what we say today could include forward-looking statements, and those carry a variety of risks and uncertainties, among them the ones described periodically within the Risk Factors portion of the documents Moelis & Company submits to the SEC. There's a chance actual outcomes will diverge significantly from what we anticipate right now. The firm assumes no duty to revise any forward-looking statements. In our remarks, we'll also cite specific adjusted financial metrics. When shown alongside comparable GAAP figures, we think these metrics help investors evaluate how we performed over multiple periods and gain a clearer picture of our operating results. You can find the reconciliation between these adjusted metrics and the applicable GAAP financial data, plus the other disclosures Reg G requires, inside the firm's earnings release, available on our Investor Relations site, investors.malls.com. At this point I'll hand things over to Navid.

Navid Mahmoodzadegan

executive
#2

Thanks, Matt. It's wonderful to be here with everyone this afternoon. We wrapped up 2025 carrying considerable momentum, and we've stepped into 2026 from a position of strength — evidenced by heightened client activity, unprecedented new business wins, and the strongest bench of talent and deepest range of expertise we have ever assembled. Fourth quarter revenues reached a record $488 million, and on a full-year basis, adjusted revenues climbed 28% to $1.54 billion. Growth of 35% in M&A powered our 2025 revenues, alongside a landmark year for our capital markets business and double-digit gains in both average fees and the count of closed transactions. Across our business, momentum keeps accumulating. Since the last time we spoke on an earnings call, we've advised on several prominent M&A deals, among them Netflix's acquisition of Warner Bros., the sale of Allied Gold to Zijin Gold, and the sale of Ventix Biosciences to Eli Lilly. Beyond M&A, we advised on USA Rare Earths' transformative partnership with the U.S. Department of Commerce, the debt restructuring of King of dula Economic City, and xEnergy's pre-IPO convert transaction. Supportive financing conditions and robust equity market performance are laying the groundwork for a busy deal environment in 2026. The scope and depth of M&A activity we witnessed late last year is widening and picking up speed. Strategics are growing even more active as Boards find the confidence to chase bigger transformational deals that build scale and best position them for swift technological change. Sponsor activity is picking up too, as valuation alignment improves and sponsors react to mounting pressure to put capital to work and return it to investors. Although larger cap transactions have been propelling the M&A market, momentum in our pipeline makes us increasingly confident that activity will spread across transaction sizes as the year goes on. On the capital markets side, our team is gaining from stronger investor appetite across growth-oriented sectors, with robust capabilities in the public and private markets alike. When it comes to capital structure advisory, we keep seeing a long runway of liability management assignments, fueled by the considerable leverage present across many companies and compounded by technology disruption that keeps accelerating. And as time passes, we expect more traditional restructurings as earlier out-of-court solutions reach the end of their course. Lastly, after substantial investment in 2025, our private capital advisory business is building real traction and is well positioned to serve our sponsor clients as the GP-led secondary market continues to reach record levels. Our thesis for this business is clearly being validated. Our PCA team is fully integrated with our industry and financial sponsor bankers, and our secondaries pipeline is developing rapidly. We continue to invest in this area, with a Managing Director focused on private credit secondaries joining next week, and with another MD joining later this year, we will have a team of 7 Managing Directors dedicated to GP-led secondaries. This growth strengthens our ability to support sponsor clients and reinforces our conviction that PCA will be an increasingly important fourth pillar of our firm. With that favorable environment in mind, we believe there's a major chance to keep expanding what our clients can do with us and where we operate. Over the course of 2025, we brought on 21 managing directors, 9 of whom came from outside the firm. Early in 2026, we elevated another 13 professionals to the Managing Director role, which puts our MD total at 178 as of this call. Those promotions, along with the hiring we keep doing, strengthen our worldwide centers of excellence and bring the firm even more in line with the biggest opportunities in the market. Thanks to how well our revenue has performed and the way our recent investments have matured, we generated considerable operating leverage this year, most notably a 320 basis point gain in our adjusted compensation ratio, which reached 65.8%. Our capital standing is still solid, with no debt and plenty of cash, and we boosted our capital return substantially via sizable share buybacks during the fourth quarter; to sum up, our coverage platform and our collaborative culture have never been in better shape, our business outlook is favorable and our pipeline sits at close to record levels; we have confidence in our capacity to keep fueling growth while producing operating leverage and creating lasting value for our clients, our shareholders and our team over the long haul. With that, I'll hand things over to Chris, who will walk through our financial results in greater detail.

Christopher Callesano

executive
#3

Thanks, Navin, and good afternoon, everyone. Record revenues came in for the fourth quarter at $488 million, which is up 11% compared with the same period a year ago. Adjusted revenues for the entire year rose 28%, reaching $1.54 billion. As Navid noted, growth in our top line was fueled by increases in M&A and capital markets on a year-over-year basis, though this was partly offset by a decrease in capital structure advisory. M&A made up roughly 2/3 of our business mix in the fourth quarter and for the full year, with non-M&A accounting for about 1/3. Now on to expenses. As Navin pointed out, our adjusted compensation expense ratios showed meaningful improvement, coming in at 61.1% for the fourth quarter and 65.8% for the full year, compared with 69% a year earlier. Adjusted noncompensation expenses totaled $60 million in the fourth quarter, which produced a noncompensation expense ratio of 12.4%. For full year 2025, adjusted noncompensation expenses reached $224 million, yielding a non-compensation expense ratio of 14.6%, down from 15.9% the previous year. Expense growth over the year was mainly driven by higher deal-related T&E and client conferences, ongoing investments in technology and data, including AI, and greater occupancy costs stemming from headcount growth. Because of our continued technology investments, along with more deal activity and headcount, we presently expect full year 2026 noncompensation expenses to increase at a rate similar to 2025. Our adjusted pretax margin came to 28.6% in the fourth quarter and 21.5% for full year 2025, which marks 510 basis points of improvement over the 16.4% adjusted pretax margin recorded in 2024. On taxes, our normalized corporate tax rate for the year stood at 29.8%, while our effective tax rate was 22.4%. That gap between the rates is largely the result of the excess tax benefit tied to delivery of equity-based compensation during the first quarter of 2025. As a reminder, in line with prior years, annual vesting of RSUs takes place later this month, and we anticipate recognizing an excess tax benefit that will have a favorable effect on Q1 EPS. EPS gains were supported by our revenue growth along with decreases in both our comp and noncomp expense ratios. Adjusted EPS for full year 2025 came in at $2.99 per share, which is 64% higher than the $1.82 per share reported in 2024. Moving to capital allocation. A regular quarterly dividend of $0.65 per share was declared by the Board. Buyback activity picked up during the fourth quarter, with 716,000 shares repurchased in the open market at an average price of $62.96 per share, which brought total repurchases for the year to approximately 950,000 shares. Through dividends, net settlement of shares and open market repurchases, we will have returned $284 million of capital to shareholders for the 2025 performance year. The Board also authorized a new share repurchase program of up to $300 million with no expiration date; and finally, our balance sheet remains strong, with $849 million of cash and no debt. With that, let's open the line for questions.

Devin Ryan

analyst
#4

Hi Navid and Chris, good afternoon — how are you both doing?

Navid Mahmoodzadegan

executive
#5

Doing well, Devin. And yourself?

Devin Ryan

analyst
#6

Things are going well. To start off, regarding the wider advisory picture — obviously 2025 was a strong year, up 28% compared to the prior year, even though sponsors weren't really at what I'd call their full potential, and sponsors are clearly a key client group for Ola. That demonstrates you folks could serve customers of many different sizes and many different kinds. But when it comes to sponsors in particular, how would you describe the rough scale of remaining upside toward something closer to a typical level, and what that means for Moelis, since you're coming off such a strong year yet it still seems like there might be another step change once sponsors genuinely reengage — I'd just like to hear your perspective and, if possible, how you'd go about putting a number on that?

Navid Mahmoodzadegan

executive
#7

Absolutely, Devin. I appreciate the question. I believe the way you've framed it is spot on. Through the course of 2025, we witnessed rising momentum in sponsor transactions. In our view, quite a bit of room remains before activity reaches the levels that would bring about a better balance between returning capital and putting it to work. I believe this applies both in terms of widening the scope for additional deals in the middle market. My sense is that arrives in 2026. That's definitely what our pipelines and our discussions with sponsors indicate. We've discussed this during many earlier earnings calls — there's a genuine drive from LPs to see capital returned from these portfolio companies. My sense is we're getting to a place where financing markets are solid, the wider economy is solid, inflation appears to be contained. And at this stage valuations are simply what they are in the market, and I believe sponsors are coming to terms with which choices exist for them to deliver returns back to their LPs. Among those choices, besides M&A, is pursuing a GP-led secondary, which is 1 of the reasons we're extremely enthusiastic about that business. We now possess an industry-leading GP-led secondary capability to combine with our industry-leading sponsor coverage and industry-leading M&A capabilities, so sponsors can be offered a solution to assist in resolving those matters. And I believe we're truly witnessing the market open up. My sense is that occurs in 2026. And I believe our positioning is very strong to capitalize on it.

Devin Ryan

analyst
#8

That's useful detail, Navid. As a quick follow-up about the restructuring liability management work — you said there's a pretty extended runway of activity. Could we break that down a bit further, in terms of how we ought to frame a base case for activity levels there? Is it roughly in line with what we've been observing, so you can more or less maintain the pace, or does it perhaps ease somewhat, yet the high — it settles at an elevated baseline? I'd really like to walk through how that shapes up at present. I understand there are clearly scenarios where a downturn in the economy would mean more activity, though that likely wouldn't be great for M&A; so I'd just like to consider the base case for what that extended runway implies. .

Navid Mahmoodzadegan

executive
#9

Sure. When we consider the base case as you describe it, our view is that this extended runway of companies does exist. A whole set of companies made use of extremely attractive financing, an extremely attractive rate and financing backdrop, to carry a substantial amount of leverage across the past several years throughout the prior cycle. There's still — certain of those businesses have gone through different phases of liability management exercises, yet plenty of balance sheets remain out of whack, frankly, compared with the scale and the earnings of those businesses. Beyond that, you're seeing technology disruption arrive, and it will hit a number of these sectors quite dramatically; so looking ahead, I believe there will simply be a great many companies that continue to have to wrestle with their balance sheet. My sense is part of that will occur via amended extends and liability management style exercises out of court; yet I believe certain of those companies will tip into more active in-court restructuring assignments; and once again, we're well positioned for all of that; on top of which, we've substantially strengthened and invested in our creditor side capabilities, so that when we aren't on the company side in these situations, we hold a really good seat working alongside creditors there. And we're genuinely enthusiastic about the growth of that business and our traction in it. So 12 months ago, you told me, bear in mind we had come off a really strong 2024 on the CSA side of the business, and we had sort of forecast that our business might decline a little, given the market backdrop. Looking ahead to this year, my prediction is flat to up rather than flat to down regarding the strength of our business in what we call CSA.

Devin Ryan

analyst
#10

Yes. That is quite useful. Thank you.

James Yaro

analyst
#11

I'd like to discuss a bit the M&A mix for 2025 and what might lie ahead in 2026 and afterward. Last year's market was driven heavily by mega cap deals. So I'd really like your view on whether large transactions can keep coming, and to set that against what's in store for smaller ones, which I believe connects to what you said about sponsors; then, stepping back, at what point and for what reason would smaller transactions close the gap with the large ones?

Navid Mahmoodzadegan

executive
#12

Well, looking ahead over the coming years, I genuinely believe there's a meaningful chance that the larger cap kind of deal — and we saw plenty of those during the last year, which was near a record on the bigger end of the transaction curve — will keep going. And my reasoning for that continuation is that these bigger companies are motivated to build greater scale so they can serve their customers, to achieve efficiencies, and to put themselves in the best position for technological change. Such motivations are only speeding up, plus you have a market and regulatory backdrop that permits such transactions — and nobody knows how long that will endure — along with a financing climate and equity market that encourage deals of that type. So we keep having very busy conversations with our clients regarding these larger transactions. That said, I believe we've reached a stage where the middle market — the one we refer to — has been quieter, since there's been something of a mismatch between what buyers and sellers expect, and because borrowing costs had climbed, making it tougher to fund new buyouts of such companies. Tariffs, inflation, and all of that made it difficult to underwrite acquiring those kinds of companies. Many of those problems have faded, and the pressure from LPs to recover their money — the pressure they apply to private equity firms — remains very much present. Therefore I think we've arrived at a moment where many financial sponsors who have held these portfolio companies for 6, 7, 8, 9 years now find it difficult to do anything except actually go to market and find out what price the market will bear for those portfolio companies. And I simply think that is happening more and more. There's genuinely no justification to hold off now, unless something particular applies to that company, where you expect a step function increase in its earnings within a year — at this point it is what it is, it's time to monetize, and I believe an increasing number of sponsors are bringing those companies to market.

James Yaro

analyst
#13

Great, that's really clear. You've highlighted plenty of positive spots. I want to zoom in on just 1 thing that's been shifting quite a bit lately — the geopolitical situation. When you're sitting in the boardroom, does that come up in conversations? Or have boards simply seen such a wide variety of geopolitical scenarios by now that they've grown more at ease with it all?

Navid Mahmoodzadegan

executive
#14

That's a terrific question. Naturally, geopolitics and events on the global stage always come up when we're sitting in boardrooms and speaking with clients about possible deals. Uncertainty tends not to be a friend to bigger corporate transactions in general. So yes, if some kind of exogenous shock were to occur — a major geopolitical flare-up — that might affect how much transaction activity we see going forward. Still, you're right. In some sense, throughout the last year, there's simply been so much going on, and folks might be growing somewhat numb to certain flare-ups, the near-term ones, and essentially saying, look, I need to do whatever's necessary to put my business in the best position I can. We're aware technology changes are on the way. We must be ready for that; we must place ourselves well for it. We're aware equity markets reward focus and execution and growth and simplicity of story; we know that's the case. So let's pursue corporate transactions that best position us for creating equity value and for handling the technology disruption headed our way. And unless there's something geopolitical very plainly visible on the horizon, people are sort of pushing through it.

James Yaro

analyst
#15

That's very clear.

Alex Bond

analyst
#16

I've got a question about the revenue picture and how you see the timing of revenue recognition unfolding across the year ahead. We're just a single month into the year so far, yet when it comes to announcements at the industry level, activity has landed a bit weaker than what most folks were anticipating; and judging by what can be seen in the public completion and pipeline data for all, Q1 in particular looks like it could come in somewhat lighter than the prior two quarters; even so, the wider backdrop is obviously still pretty favorable; so I'm interested in how you're approaching this, and maybe whether you expect revenues to lean more heavily toward the back half of this year as things continue improving. Yeah, any perspective on that would be terrific.

Navid Mahmoodzadegan

executive
#17

Yes. Alex, thanks for asking. I really don’t want us to read too much into a single month or one moment in time. What I can share is this: as we’ve discussed before, the conditions for deals look very favorable and supportive, and our clients are highly motivated to get transactions done. Our activity for generating new business is at record levels, and our pipeline is also at record levels. So predicting exactly how that shows up in any given month or quarter is always somewhat difficult. Still, you make a fair point — when conditions get better, Q1 is usually the softest stretch from a seasonal standpoint, then things pick up as the months go on. That's exactly what happened for us during the past year. So I'd rather not forecast how Q1 will stack up against Q2 or anything like that. My view is simply that when you consider what lies ahead for 2026 and the years after, we feel a great deal of optimism.

Alex Bond

analyst
#18

Understood. No, that's reasonable. It makes sense. — so perhaps as a follow-up, regarding comps. There was genuinely strong leverage in both the quarter and the full year. But considering, once more, 2026, should the year unfold as anticipated in terms of the revenue setup and volumes pick up, at a healthy pace. Could you share your latest thinking on the timing of possibly reaching that low 60s normalized range you've mentioned before.

Navid Mahmoodzadegan

executive
#19

Yes, absolutely. Appreciate the question. Look, we're very happy with what we've managed in lowering that comp ratio. As a quick reminder, our comp ratio had been elevated while market revenues were softer and we were investing heavily in the business and recognized the chance to truly propel our business forward, moving from 83% in 2023 to 69% last year and now 65.8%. So we're quite happy with that improvement. I believe we can keep doing even better than 65.8% to your — regarding your question, how much more we can achieve in 2026, I think will truly hinge on 3 factors: One is what revenues we generate in 2026. That's always a crucial driver when it comes to the leverage we can build in the model. Second, what's the landscape for banker pay and rivalry for bankers. It's a competitive market out there. We've noted that on earlier calls, and we clearly need to safeguard our base of excellent bankers we have, and we aim to keep expanding. And our capacity to locate excellent bankers who suit the culture, who are industry leaders and big TAMs, it isn't simple to find those individuals. And when we do locate those individuals and they wish to come, if we can strike a reasonable deal with them, we want to bring them aboard. And so how many of those individuals we can bring aboard in 2026 will likewise affect the specific comp ratio in that particular year. So we attempt to balance all of that. We want to lower the ratio. I think we're dedicated to doing that. But we want to do that while still capitalizing on all the opportunities we see ahead of us, all the great dialogues we're having with bankers who want to join the firm and trying to get more and more of those individuals to join so we can pursue this great opportunity we see ahead of us.

Brendan O'Brien

analyst
#20

To begin with, Naved, you touched on this somewhat during your prepared remarks, but one of the major subjects people are debating right now is AI disruption and what it might mean for the future of M&A activity. On one hand, I recognize this could drive more strategic activity, yet since software companies make up a sizable chunk of inventory, there's a danger they might find it hard to exit a meaningful share of their portfolios. So I was hoping to hear how you see these competing forces and whether you've noticed any effect on your conversations regarding some of these PE software companies? .

Navid Mahmoodzadegan

executive
#21

Thank you, Brendan. Look, I believe that's a great question, and I think the way you've framed it is exactly right. As we discussed previously, I think across many different areas of the economy and various industries, AI disruption and technology shifts act as accelerants of M&A activity. And in other portions of the ecosystem, though we haven't observed it yet — there isn't a single instance I could cite where AI has generated a restructuring opportunity in the near term. That will likely arrive at some point. Software is drawing considerable attention lately. The public markets are plainly lowering the multiples on software companies, and SaaS companies are declining because people fear the danger to the business model that AI presents. Eventually, that might affect those companies' capacity to finance themselves, and that might produce transactions resembling liability management transactions more than M&A transactions. And so we're tracking all of that. We're clearly engaged in ongoing conversations with all our clients regarding all those trends. I think you're correct to highlight that disruption might have an opposing effect with respect to M&A, but it also might generate other chances for us to advise clients that must handle balance sheets in those areas that are experiencing strain. So it's early days. We're watching it very closely and above all, look, our business is providing advice. And disruption opens the door for us to grow closer to our clients and assist them in navigating those periods.

Brendan O'Brien

analyst
#22

That's useful context. For my second question, I was hoping to hear where things stand on the schedule for building out PCA. From what you've said before, I understand you believe this operation can reach a couple of hundred million in revenues, though the growth curve will probably be fairly nonlinear. So I'd like to understand how we ought to frame the path ahead as we move into next year — specifically, how much progress along that path might be achieved by 2026.

Navid Mahmoodzadegan

executive
#23

Making a precise 2026 forecast isn't something I want to do. What I can tell you is this: the group we are assembling is one we're very excited about; the conversations we're having with other people who might come aboard are ones we're very excited about, and the initial response from our PE clients has been outstanding. The thesis behind this is exactly right. Our ties within the sponsor community are tremendous, and they go back a long way and run deep, plus our coverage teams perform excellently in that area. Our industry bankers are exceptional, and this capability was the piece we lacked, since it lets us actually sit down with sponsors and discuss GP-led secondaries. Those discussions are now happening, we're securing mandates and carrying them out, and the ramp is unfolding almost precisely as I expected it to; furthermore, I believe the chance for this to become a highly significant business for us — much like our CSA businesses, much like how our capital markets has ramped — is there. My sense is it will be a business of exactly that sort when it comes to size, scale, and quality; the only open question is the timeframe over which that materializes. And my optimism is that we can get there across the coming few years.

Brennan Hawken

analyst
#24

I believe that marks our first slip from Brendon to Brennan. Anyway, moving on. Navid, I appreciate what you said regarding uncertainty around comp leverage. But since our marketplace is quite busy, it likely makes sense that good bankers would hesitate to leave, since they wish to remain available for their clients amid heightened competition for talent — meaning those costs exist. So why not dial things back somewhat on the recruiting front right now? Not altering what's possible for us, just acknowledging this may not be the ideal moment. How do you think about that trade-off?

Navid Mahmoodzadegan

executive
#25

Brendan, that's a solid question. Look, the only transactions we'll pursue are ones that serve the firm over the long term and suit our firm's culture. But these people — a singularly gifted person in a space we're targeting, or a sector we're targeting, who also matches our culture — that's a demanding standard; an extremely, extremely demanding bar to clear. And once such a person emerges and you begin talking with them, you understand they will make a move. Plus, when they do move, they're likely unavailable for several years. These days bankers aren't like college football players, constantly trading themselves and marking themselves to market annually. They'll stay at a firm for some stretch of time. So when you encounter that individual who's ideal for your platform — and again, culture matters enormously — we aren't merely bringing on excellent bankers; we're bringing on excellent bankers who wish to be part of a team, a collaborative team. And when that individual emerges, and you have a productive conversation, and they're prepared to leave for whatever reason — they don't like their firm, they feel they weren't compensated properly, something occurs within their firm that they dislike, or their firm disappoints them on some assignment — when that individual emerges, you might miss out on them for several years should you fail to act. Consequently, we can't always dictate when things happen, and such people are one of a kind. They don't grow on trees. So look, we're highly mindful of how fast we proceed. We're highly mindful of our capacity to bring people aboard properly and ensure we can launch them correctly with adequate support. And we're highly mindful regarding deal structure. Beyond all that, some of the timing rests somewhat outside our control. That said, as we've previously stated, the comp ratio, plus our capacity to gain leverage and our capacity to ensure we're being careful there, sits at the very top of our concerns when we consider the company's growth.

Brennan Hawken

analyst
#26

That's genuinely useful for how I'm thinking about this. Thanks for that response, Navid, and clearly, you folks have managed the comp leverage well as of late. So that's something we can point to. To build on one of Brendan's questions. When you look at software and IT services inside your sponsor franchise. It's somewhat difficult since public information isn't particularly good at showing everything you're doing. How significant are those areas for your banking and activity-driven business; and I realize you mentioned it could be somewhat fluid, it might move from an M&A conversation to a liability management conversation; so thinking broadly across MoIs, are those a major area for you? My impression has always been that they were, but I'm interested in the size.

Navid Mahmoodzadegan

executive
#27

Sure, Brian. Look, as I believe you're aware, we made a significant investment, a truly excellent investment in a fantastic technology franchise and technology team a few years back. That effort has worked out very well and technology, generally, is essentially at the top of the list now among our most productive sectors at the firm; and within technology, software represents a very large portion of that. So you're correct that we have plenty of dialogue and plenty of client connectivity to both the sponsors and the companies that fall broadly within the software sector. And then again, when you consider products, it isn't only liability management; so if a sponsor owns a technology company or a software company, that conversation can be M&A. It might be raising bespoke capital, more of a capital markets style transaction to either provide a sponsor some liquidity or address a balance sheet challenge. It might be a CV or it might be liability management, correct? And so having the ability now for the first time since our founding to be extremely versatile and extremely fluid across 4 products that could apply to that software company or that technology company. It's the first time since our founding, we've been capable of truly doing that in a meaningful way with a top technology franchise with a great sponsor coverage team; so we're going to be there to assist our clients in finding solutions as the market changes and as they're handling the disruption that's arriving in that space, for example.

Ryan Kenny

analyst
#28

Over the past several years, you've brought on a lot of people, and it sounds like you'll keep being opportunistic going forward. Is there a way for us to think about what percentage of MDs are currently ramped? And perhaps what percentage since 2021 are ramped?

Navid Mahmoodzadegan

executive
#29

Yes. Let me share some figures with you. That's a great question, Ryan. Roughly 1/3 of our MDs have held the MD title on the platform for fewer than 3 years, and approximately 1/4 of our MDs have been MDs on the platform for fewer than 2 years. And when I say — just to be clear, when I refer to MDs on the platform, that means either laterals we hired or internal promotions. So that covers both of those groups; and to this point, we remain a firm that is still maturing into its talent base, a very, very significant share of our MDs are younger MDs or MDs who haven't been on the platform for a long stretch of time. And so the best years of those MDs, the most productive years of those MDs are truly ahead of them as they settle into the platform, as they bring their clients to the platform, as they grow as bankers. And that's 1 of the things that excites me so much — just such a high-quality talent level of people whose brightest days are in front of them as they work alongside their counterparts in other parts of the firm and as they bring the firm to their clients.

Ryan Kenny

analyst
#30

And when you're expanding PCA, does it take much less time for MDs and private capital advisory to get up to speed compared with standard M&A? I'm just trying to get a sense — as you push further into PCA, does that put less pressure on the comp ratio since the MDs are able to ramp more quickly?

Navid Mahmoodzadegan

executive
#31

Yeah, I believe that's an excellent question, since keep in mind, the sponsor relationships are already in place, and they go back a long way — the industry relationships are already there too, they go back a long way, and it's an expanding platform of industry relationships as we bring on strong sector bankers. So actually, it's amusing. I was — oh, I brought Matt West, who leads our group, to visit a client last week. This is a client we had already completed capital raising for, and we were considering doing M&A for. And the client mentioned, I might want to do a CV, and I had mapped there the following day. And so there's no ramp-up needed there, because that's already a client of the firm. We just — we lack that product capability. We would have lost that opportunity if it wasn't there. And so I think relevant to what you asked, much of the ramp-up there is occurring rapidly since we're simply inserting a product set into an existing set of relationships, and it's performing really wonderfully.

Nathan Stein

analyst
#32

You pointed out in the release that revenues from M&A and capital markets went up in 4Q, whereas capital structure advisory declined. Could you quickly walk through what's happening with the PCA business compared with the fourth quarter of last year?

Navid Mahmoodzadegan

executive
#33

Sure. Keep in mind PCA is still ramping up, so that team has really coalesced during the back half of this year, and as a result most of what they're doing is still securing new mandates and bringing in new business — you won't see much in the way of actual revenues in the fourth quarter or in 2025 from that business. I think we'll see far more meaningful revenue growth on PCA as we move into 2026.

Nathan Stein

analyst
#34

All right, that's reasonable. I also value the openness. For my next question, I'd like to discuss capital allocation. Regarding the buyback authorization of $300 million that was announced, can you share any perspective on the timing we should have in mind?

Navid Mahmoodzadegan

executive
#35

Certainly. Once more, it could be useful to walk through our thinking on excess capital. We enjoyed a strong year, and our revenue growth has us quite pleased. Strategically, we accomplished everything necessary when it came to hiring and to technology investments of the kind Chris mentioned. As a result, we've still generated substantial excess cash. We do have a dividend, and protecting and maintaining that dividend comes first. Beyond the dividend, we had a considerable amount of excess cash this year, and much of it went toward share repurchase, particularly during the fourth quarter. So that's the way I believe we'll approach prioritization moving forward: expand the business within sensible boundaries, as we discussed in connection with the earlier questions. We'll make the investments required in our people, our technology, client conferences, and similar items — everything essential for growing the business over the long term. The dividend is something we're dedicated to sustaining. Past that, we do aim to reduce some of the share dilution caused by our equity issuances for compensation, and we're dedicated to doing so to the extent it's sensible, all while preserving an extremely strong balance sheet, which we view as a genuine strategic advantage. Given that this business has some cyclicality, it simply makes complete sense to us to hold onto dry powder, retain optionality on the balance sheet, and ensure we can endure any market conditions.

Analyst

analyst
#36

Over the last 12 months, has regulatory scrutiny on the G-SIB eased? And did that line up with bulge brackets stepping up their pursuit of more deal mandates — how would you characterize Mellis' capacity to take market share in a deregulatory environment?

Navid Mahmoodzadegan

executive
#37

Sure. My sense is it likely varies somewhat depending on the sectors in question, and certain sectors may differ from others. I'm not seeing competition that's meaningfully stronger than what's shown up in recent years from bulge brackets that weren't strong to begin with. Obviously, we face tough bulge bracket competition from a small number of firms. They've consistently been tough, and they will stay tough. . So I don't — that's simply the reality, and it's how things have always been. As for that second group of bulge-bracket firms, I don't perceive anything meaningfully different from how it's been previously. And plainly, the momentum I'm seeing on the client side is really us going up against other independent firms that have genuinely good people, that are entrepreneurial and nimble, and that possess plenty of strong intellectual capital and ideas. To me, that feels like the space where we operate in our part of the market is where much of the activity is happening and where incremental market share is being picked up. And that — naturally, we do compete with the bulge bracket. But frequently, our competitors are independent firms similar to us.

Ken Worthington

analyst
#38

If we return to compensation for the last two years, you set the comp ratio, began the year with it, and later—whether in the back half or the fourth quarter—revised both pay and that ratio according to observed activity levels. So when we consider 2026 and the point where the year begins, what starting comp ratio do you expect, simply to assist us somewhat in modeling the opening portion of the year?

Navid Mahmoodzadegan

executive
#39

Yeah. My expectation is that we'd keep a comp ratio comparable to the one at which we finished the year, meaning 65.8%. As you noted, Q1 is generally too soon to forecast what the rest of the year holds. Later quarters, I'd anticipate, will bring changes, provided nothing unusual occurs. One more thing to keep in mind: retirement eligible equity granted during Q1 is expensed by us in full. Therefore, the Q1 ratio might not reflect the entire year, depending on revenues.

Navid Mahmoodzadegan

executive
#40

Excellent. Thanks to each of you for being here. I truly appreciate that you're on this call, and I'm eager to talk with all of you again before long. Thank you.

Operator

operator
#41

That wraps up today's session, everyone, and we appreciate your being with us. You're free to hang up at this point.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Moelis & Company transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Moelis & Company earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Moelis & Company or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.